CDH17 and neoplasm: These results can explain the extent of tumor migration and invasion processes from the tumor core and, consequently, EPNI through the loss of intercellular adhesion, indicated by low CDH17 levels, or the limitation of these processes by maintaining high CDH17 levels, and, subsequently, a low Bd score (Bd1).